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We conducted a preliminary comparison of the relative 
sensitivity of a cross-section of published human rhinovirus 
(HRV)–specifi c PCR primer pairs, varying the oligonucle-
otides and annealing temperature. None of the pairs could 
detect all HRVs in 2 panels of genotyped clinical speci-
mens; >1 PCR is required for accurate description of HRV 
epidemiology.
Human rhinoviruses (HRVs) cause more asthma ex-acerbations than any other known factor, in addition 
to causing most colds and infl uenza-like illnesses. The 
prevalence of HRV in published reports varies consider-
ably. A novel HRV clade identifi ed in 2006, now known 
as HRV species C (HRV-C) (1), can be identifi ed only by 
PCR. Since 1988, seasonality and clinical outcomes and 
numerous different primer pairs have been used to identify 
HRV; how well these methods perform on new HRV types 
is uncertain. Given the likely variation in the preparation of 
RNA, the quality and formulations of commercial reverse 
transcription (RT)-PCR enzymes and reaction mix compo-
nents and changes in thermal cyclers since 1988, not sur-
prisingly many, perhaps most, of these assays are not be-
ing used in the manner they were originally described. For 
example, the fi rst HRV-specifi c primers reported (2) have 
subsequently been used with different RNA preparation 
methods, amounts of reverse transcriptase, cDNA priming 
strategies, dNTP concentrations, annealing temperatures 
(TMs), and cycling conditions (3,4).
The Study
We conducted a preliminary comparison of the relative 
sensitivity of a cross-section of published HRV-specifi c 
PCR primer pairs (most of which were fi rst published be-
fore HRV-C was reported), independent of most variables 
described above, by testing a panel of 57 clinical specimen 
nucleic acid extracts from combined nose and throat swabs 
from preschool children with colds and infl uenza-like ill-
nesses in Melbourne, Australia. The study was approved 
by the Royal Children’s Hospital Human Research Ethics 
Committee. The panel included representatives of the 3 
HRV species (Figure), human enteroviruses (HEVs), and 
extracts negative for picornaviruses. The HRVs had been 
previously detected by using a nested primer pair (online 
Appendix Table, www.cdc.gov/EID/content/17/2/294-
appT.htm) (5). We used 10 different HRV primer pairs and 
also retested specimens by using the original primer pair 
with our standard reagents and equipment (5). We applied 
the published TM when possible. The original descriptions 
of primer pairs 7 and 10 (online Appendix Table) lacked 
TM information, and after in-house calculations, we used 
TMs of 50°C and 58°C, respectively. We also deliberately 
standardized the reagents (OneStep RT-PCR kit, QIA-
GEN, Doncaster, Victoria, Australia) and thermal cyclers 
used (Veriti, Applied Biosystems, Foster City, CA, USA) 
for conventional PCR and the RotorGene 3000 real-time 
cycler (QIAGEN). Because primer pair 1 had a published 
history of detecting types from all HRV species, we chose 
it to genotype HRV-positive samples by sequencing the 
amplifi ed products. Other pairs were used if pair 1 was un-
successful.
We found that no primer pair detected the same HRVs 
and HEVs typed when the original pair (5) or pair 1 (online 
Appendix Table) was used. Five primer pairs, including 
real-time PCR (rtPCR) pair 5, did not amplify the HEVs, 
a positive feature for HRV-specifi c studies. Only 2 primer 
pairs amplifi ed anything from a specimen that was positive 
for both HRV and HEV, a problem for accurate estimation 
of the frequency of co-detections. The original primer pair 
screen detected 3 untypeable picornaviruses, which were 
not detected by any other pair or by repeat testing using the 
same pair. Only the second-round amplicon of the 3 nested 
sets of nested primer pairs (2, 3, and 9) was considered be-
cause the second round increased the total number of posi-
tive specimens over the fi rst round. The longest amplicon, 
produced by primer pair 7, was also a valuable genotyping 
target, but it detected only 14 of the original 27 HRV-posi-
tive specimens in this population.
We next selected 4 frequently published primer pairs 
(1, 5, 7, and 8) to examine 44 picornavirus-positive speci-
mens (39 HRVs, 3 HEVs, and 2 untypeable picornaviruses) 
from nonhospitalized children with acute asthma exacerba-
tion (6). As before, primer pair 1 detected the greatest num-
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ber of HRV- and HEV- positive specimens and all positive 
specimens detected by other primer sets (n = 41), followed 
by pair 7 (n = 40), pair 5 (n = 36), and pair 8 (n = 31). 
Most notably, primer pair 7 performed better than it had in 
the previous population, detecting only 1 fewer HRV than 
primer pair 1 and 9 more HRVs than pair 8. No species-
specifi c bias was apparent, but generally, a specimen with a 
lower RNA concentration, as indicated by the cycle thresh-
old from primer pair 5, was less likely to be detected or 
typed by using other primer pairs. Primer pairs 5 and 8 did 
not detect the 3 HEVs (HEV-68). We noted in both popu-
lations that primer pair 1 sometimes amplifi ed a region of 
human genomic DNA from chromosome 6 (GQ497714), 
for which amplicon size was indistinguishable from that 
expected due to HRV.
It was not possible to use the precise conditions re-
ported for the 10 compared assays; 1 was published >2 de-
cades ago and used phenol chloroform extraction. Some of 
the original enzyme formulations or reagents are no longer 
available, and production processes have changed in the 
interim. Thermal cyclers have also changed. There was no 
consensus on enzymes and reaction mixes used. In addi-
tion, the previously published primers were used in assays 
divided between those using 1-step RT-PCR and those us-
ing a separate RT cDNA synthesis step. A review of studies 
that detected HRVs with adequately described conditions 
during 2009–2010 found that fewer used a single-tube RT-
PCR approach than a 2-step system. We conducted single-
tube RT-PCR to maintain the benefi ts of the so-called 
closed amplifi cation system of rtPCR. Thus, we chose to 
use a single common set of reagents as the fairest way to 
compare the primer pairs examined in this study. We be-
lieve the nature of this relative comparison best refl ects 
performance for the likely end users: clinical microbiology 
laboratories or researchers.
We compared primers rather than assay function us-
ing clinical material instead of cultured virus, plasmid or 
synthetic RNA standards, or screening contemporary or 
archived extracts, which are sometimes of low viral load. 
When picornavirus epidemiology is the primary research 
focus, we recommend using >2 primer pairs to maximize 
the detection of HRVs. Under our conditions, pairs 1–4 re-
turned the highest number of positive results, and the rtP-
CRs behaved similarly but with reduced sensitivity. The 
rtPCR that used pair 5 did not amplify known HEVs.
Many possible reasons could cause discrepant virus 
testing results between different sites, including changes 
to specimen integrity resulting from transport and variable 
amplifi cation resulting from low viral loads. The effects of 
viral load can be seen in this study: specimens in popula-
tion 1 that were positive with multiple (>6 separate pairs) 
primer pairs had a mean cycle threshold of 33.3 (combining 
results from both rtPCRs), whereas those with <6 positive 
results had means of 39.3 cycles. Most (29/33) specimens 
with <3 positive primer pairs were negative by rtPCR. Am-
plifi cation variability can also be attributed to the substan-
tial nucleotide sequence diversity between HRVs and the 
different temporal and clinical characteristics of the 2 spec-
imen populations we used. Population diversity is a feature 
of HRV studies in the literature.
Conclusions
Our selection of published primer pairs includes those 
from studies that have informed our current understand-
ing of HRV epidemiology. Finding such a high degree 
of variability in performance was thus noteworthy. Inef-
fi cient HRV detection by PCR may be a serious problem 
for research studies. Comparison of data between different 
HRV studies is confounded as are data from studies seek-
ing to determine the effects of other respiratory viruses. 
The prevalence, seasonality, transmission, and clinical ef-
fects of HRV types and species require reexamination with 
tools that have been comparatively validated to ensure their 
sensitivity.
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Figure. Distribution of human rhinovirus (HRV) and human 
enterovirus (HEV) sequences used for primer pair studies. The 
HRV and HEV genotypes from the testing panel (indicated 
by fi lled circles) were aligned with the central 154 nt of the 5′ 
untranslated region (UTR) region of all complete HRV genomes 
and poliovirus-1. HRV-Ca and HRV-Cc refer to HRV-Cs with 5′ UTR 
sequences that have phylogenetic origins from either HRV-As or 
HRV-Cs, respectively. The tree was constructed by neighbor joining 
of maximum composite likelihood distance implemented in MEGA 
(www.megasoftware.net).
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